Effects over two years of verteporfin therapy on choroidal neovascularization secondary to the ocular histoplasmosis syndrome (VOH study)

被引：0
|
作者：
Saperstein, DA [1 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2002年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
982
引用
收藏
页码：U215 / U215
页数：1
相关论文
共 50 条
  • [1] Ocular photodynamic therapy with verteporfin for choroidal neovascularization secondary to ocular histoplasmosis syndrome
    Busquets, MA
    Shah, GK
    Wickens, J
    Callanan, D
    Blinder, KJ
    Burgess, D
    Grand, MG
    Holekamp, NM
    Boniuk, I
    Joseph, DP
    Thomas, MA
    Fish, E
    Bakal, J
    Hollands, H
    Sharma, S
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2003, 23 (03): : 299 - 306
  • [2] Four-year results of verteporfin therapy for choroidal neovascularization (CNV) secondary to the ocular histoplasmosis syndrome (OHS): Second year of an open-label extension of the VOH Study
    Aaberg, T
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U904 - U904
  • [3] Verteporfin photodynamic therapy of choroidal neovascularization secondary to ocular toxoplasmosis
    Wirthlin, R
    Song, A
    Song, J
    Rosenfeld, PJ
    ARCHIVES OF OPHTHALMOLOGY, 2006, 124 (05) : 741 - 743
  • [4] Photodynamic therapy for choroidal neovascularization in ocular histoplasmosis syndrome
    Xu, S
    Meyer, D
    Yoser, S
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U114 - U114
  • [5] INTRAVITREAL BEVACIZUMAB FOR CHOROIDAL NEOVASCULARIZATION SECONDARY TO PRESUMED OCULAR HISTOPLASMOSIS SYNDROME
    Ehrlich, Rita
    Ciulla, Thomas A.
    Maturi, Raj
    Kheradiya, Nisha S.
    Hrisomalos, Nick
    Shulman, Shiri
    Guess, Matthew G.
    Coyle, Ellen
    Harris, Alon
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2009, 29 (10): : 1418 - 1423
  • [6] A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes
    Sickenberg, M
    Schmidt-Erfurth, U
    Miller, JW
    Pournaras, CJ
    Zografos, L
    Piguet, B
    Donati, G
    Laqua, H
    Barbazetto, I
    Gragoudas, ES
    Lane, AM
    Birngruber, R
    van den Bergh, H
    Strong, HA
    Manjuris, U
    Gray, T
    Fsadni, M
    Bressler, NM
    ARCHIVES OF OPHTHALMOLOGY, 2000, 118 (03) : 327 - 336
  • [7] Photodynamic therapy for juxtafoveal choroidal neovascularization due to ocular histoplasmosis syndrome
    Shah, GK
    Blinder, KJ
    Hariprasad, SM
    Thomas, MA
    Ryan, EH
    Bakal, J
    Sharma, S
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2005, 25 (01): : 26 - 32
  • [8] Treatment outcomes of choroidal neovascularization secondary to ocular histoplasmosis
    Comer, GM
    Ciulla, TA
    Gao, H
    Maturi, K
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [9] Smoking as a Risk Factor for Choroidal Neovascularization Secondary to Presumed Ocular Histoplasmosis Syndrome
    Chheda, Lena V.
    Ferketich, Amy K.
    Carroll, C. Patrick
    Moyer, Paul D.
    Kurz, Daryl E.
    Kurz, Paul A.
    OPHTHALMOLOGY, 2012, 119 (02) : 333 - 338
  • [10] Choroidal neovascularization with granulomatous inflammation in ocular histoplasmosis syndrome
    Mann, ES
    Fogarty, SJ
    Kincaid, MC
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2000, 130 (02) : 247 - 250
12345